Journal article
Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable b-cell neoplasms: a report of two pilot clinical trials and laboratory investigations
Abstract
Based on earlier clinical and preclinical investigations, we designed two different pilot trials for patients with nodular lymphoma or chronic lymphocytic leukemia. These studies evaluated the use of either 41.8 degrees C whole body hyperthermia (WBH), or the nonmyelosuppressive chemotherapeutic drug, lonidamine (LON), as an adjunct to total body irradiation (TBI) (12.5 cGy twice a week, every other week for a planned total dose of 150 cGy). …
Authors
Robins HI; Longo WL; Steeves RA; Cohen JD; Schmitt CL; Neville AJ; O'Keefe S; Lagoni R; Riggs C
Journal
International Journal of Radiation Oncology • Biology • Physics, Vol. 18, No. 4, pp. 909–920
Publisher
Elsevier
Publication Date
April 1990
DOI
10.1016/0360-3016(90)90416-h
ISSN
0360-3016